Why the study?
Pulmonary hypertension is a chronic progressive disease affecting quality of life, but the prevalence of mood disorders among these patients in Saudi Arabia was unknown.
What is the prevalence of anxiety and depression in patients with pulmonary hypertension in Saudi Arabia, and how does it affect health-related quality of life?
What is the prevalence of anxiety and depression in patients with pulmonary hypertension in Saudi Arabia, and how does it affect health-related quality of life?
The prevalence of anxiety and depression in Saudi Arabian patients with pulmonary hypertension is relatively low (10% and 14%, respectively) but negatively impacts health-related quality of life.
Anxiety/depression was associated with worse HRQoL in this Saudi PH cohort; leaves open need for screening and confirmatory studies.
Background Pulmonary Hypertension (PH) is a chronic progressive disease which affects quality of life. The prevalence of mood disorders in PH patients in Saudi Arabia is not known. Objectives This is a prospective observational study to investigate the prevalence of anxiety and depression in patients with pulmonary hypertension and its effect on health-related quality of life (HRQoL). Methods Forty-two PH patients were evaluated for mood disorders by using Hospital Anxiety and Depression Scale (HADS) and health related quality of life was assessed with The Short Form 36 (SF-36) Health Survey questionnaire. Results Mean age for the cohort was 42.8 (±13.3) years and 31(73%) were female. Mean pulmonary artery pressure was 46.4 (± 15) mm Hg and 25 (60%) patients had severe PH (mPAP ≥45 mmHg). Thirty-eight (90%) patients were in World Health Organization Functional Class (WHO-FC) II/III and 5 (10%) class IV. HADS anxiety and depression score was positive (11-21) in 4 (10%) and 6 (14%) patients respectively. Presence of anxiety and/or depression affected HRQoL. Conclusion Prevalence of anxiety and depression in PH patients in Saudi Arabia is low (10% and 14% respectively) compared to published studies. The low prevalence may be explained by cultural and social differences and strong family support.
No takes yet. Share an insight, caveat, or question.
Saleemi et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: